Clinical Trial 14241

Draper, UT 84020


Study Summary:

A safety and efficacy comparison of two FDA approved medications to control high blood pressure.

Bystolic (nebivolol) and Diovan (valsartan) are being compared in this research study. Both drugs are approved by the FDA for the treatment of high blood pressure.

And up to 15 visit, 16 week study. Clinic visits are performed in the mornings (0700 to 1030).


Qualified Participants Must:

• Have stage 1 or 2 high blood pressure
• If treated, be currently with medication for high blood pressure, have a diastolic blood pressure reading of 90-110 mmHg
• Be newly diagnosed high blood pressure patients who have never received medication must have a diastolic blood pressure reading of 95 to 110 mmHg
• Other qualifications apply


Qualified Participants May Receive:

Study related medical care, laboratory evaluations, close monitoring of blood pressure, study medication or placebo, and up to $750 for attending all study visits.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.